leadf
logo-loader
viewMidatech Pharma PLC

Midatech hires former Shire finance director Stephen Stamp as CFO

Stamp was FD at both Shire and Regus when they completed their initial public offers on the London Stock Exchange, as well as overseeing a number of major acquisitions and financings

Midatech Pharma PLC -

Midatech Pharma PLC (LON:MTPH) has appointed former Shire Pharmaceuticals finance director Stephen Stamp as its new chief financial officer with immediate effect.

Stamp was FD at both Shire and Regus when they completed their initial public offers on the London Stock Exchange, as well as overseeing a number of major acquisitions and financings.

As well as at Shire, he has held senior positions in a number of healthcare companies, including as chief operating officer of Xanodyne Pharmaceuticals and most recently with AIM-quoted Ergomed PLC.

After being promoted from CFO to CEO, Stamp stood down from Ergomed earlier this year.

Nick Robbins-Cherry has stepped down as CFO after five years at Midatech but will remain employed until the end of October as part of the handover process.

Chief executive Craig Cook said Stamp’s career “makes him very well suited to support the execution of our strategy at this important and exciting time for the company”.

He added: “I very much look forward to working closely with him to drive forward the development of our business as we focus on getting our clinical research assets through clinical development, approval, and onto successful commercialisation.”

Quick facts: Midatech Pharma PLC

Price: 27.5 GBX

AIM:MTPH
Market: AIM
Market Cap: £17.34 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Cabral Gold adds 2nd drill rig as company identifies new high-grade veins

Cabral Gold (CVE: CBR-OTC: CBGZF) CEO Alan Carter joined Steve Darling from Proactive Vancouver with news the company has identified at least six new NE trending high-grade veins in the Machichie SW area located immediately north of the MG deposit. Carter telling Proactive what had led them...

2 days, 6 hours ago

2 min read